Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: Value and limitations

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue SUPPL. 1, 2009, Pages 122-135

  Britto, Constança Carvalho ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Chagas disease; Chemotherapy; Cure assessment; Molecular diagnosis; Trypanosoma cruzi

Indexed keywords

TRYPANOSOMA CRUZI;

EID: 68949203206     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000900018     Document Type: Article

References (134)

1. Andrade AL, Martelli C.M, Oliveira RM, Silva SA, Aires AI, Soussumi LM, Covas DT, Silva LS, Andrade JG, Travassos LR, Almeida IC 2004. Short report: benznidazole efficacy among Trypanosoma cruzi-infected adolescents after a six-year follow-up. Am J Trop Med Hyg 71: 594-597.
2. Andrade AL, Zicker F, de Oliveira RM, Almeida Silva S, Luquetti A, Travassos LR, Almeida IC, De Andrade SS, de Andrade JG, Martelli CM 1996. Randomized trial of efficacy of benznidazole in treatment of early Trypanosoma cruzi infection. Lancet 348: 1407-1413.
3. Andrade SG, Figueira RM, Carvalho ML, Gorini DF 1975. Reaction of the Trypanosoma cruzi strains to the experimental therapeutical response to Bay 2502 (results of long term treatment). Rev Inst Med Trop Sao Paulo 17: 380-399.
4. Andrade SG, Freitas LAR, Peyrol S, Pimentel AR, Sadigursky M 1988. Trypanosoma cruzi antigens detected by immunoelectron microscopy in the spleen of mice serologically positive but parasitologically cured by chemotherapy (preliminary report). Rev Soc Bras Med Trop 21: 41-42.
5. Andrade SG, Freitas LAR, Peyrol S, Pimentel AR, Sadigursky M 1991. Experimental chemotherapy of Trypanosoma cruzi reveals infection persistence of parasite antigens and positive sorology in parasitologically cured mice. Bull World Health Organ 69: 191-199.
6. Andrade SG, Magalhães JB 1996. Biodemes and zymodemes of Trypanosoma cruzi strains: correlations with clinical data and experimental pathology. Rev Soc Bras Med Trop 30: 27-35.
7. Andrade SG, Magalhães JB, Pontes AL 1985. Evaluation of chemotherapy with benznidazole and nifurtimox in mice infected with Trypanosoma cruzi strains of different types. Bull World Health Organ 63: 721-726.
8. Andrade SG, Rassi A, Magalhaes JB, Ferriolli Filho F, Luquetti AO 1992. Specific chemotherapy of Chagas disease: a comparison between the response in patients and experimental animals inoculated with the same strains. Trans R Soc Trop Med Hyg 86: 624-626.
9. Andrade ZA, Andrade SG, Sadigursky M 1987. Enhancement of chronic Trypanosoma cruzi myocarditis in dogs treated with low doses of cyclophosphamide. Am J Pathol 127: 467-473.
10. Apt W, Aguilera X, Arribada A, Perez C, Miranda C, Sanchez G, Zulantay I, Cortes P, Rodriguez J, Juri D 1998. Treatment of chronic Chagas disease with itraconazole and allopurinol. Am J Trop Med Hyg 59: 133-138.
11. Apt W, Arribada A, Zulantay I, Solari A, Sánchez G, Mundana K, Coronado X, Rodríguez G, Gil LC, Osuna A 2005. Itraconazole or allopurinol in the treatment of chronic American trypanosomiasis: the results of clinical and parasitological examinations 11 years post-treatment. Ann Trop Med Parasitol 99: 733-741.
12. Avila HA, Borges-Pereira J, Thiemann O, de Paiva E, Degrave W, Morel CM, Simpson L 1993. Detection of Trypanosoma cruzi in blood specimens of chronic chagasic patients by polymerase chain reaction amplification of kinetoplast minicircle DNA: comparison with serology and xenodiagnosis. J Clin Microbiol 31: 2421-2426.
13. Avila HA, Sigman DS, Cohen LM, Millikan RC, Simpson L 1991. Polymerase chain reaction amplification of Trypanosoma cruzi kinetoplast minicircle DNA isolated from whole blood lysates: diagnosis of chronic Chagas disease. Mol Biochem Parasitol 48: 211-222.
14. Bellotti G, Bocchi EA, de Moraes AV, Higuchi ML, Barbero-Marcial M, Sosa E, Esteves-Filho A, Kalil R, Weiss R, Jatene A, Pileggi F 1996. In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease. Am Heart J 131: 301-317.
15. Berger A, Preiser W 2000. Viral genome quantification as a tool for improving patient management: the example of HIV, HBV, HCV and CMV. J Antimicrob Chemother 49: 713-721.
16. Bittencourt AL 1992. Possible risk factors for vertical transmission of Chagas' disease. Rev Inst Med Trop São Paulo 34: 403-408.
17. Blanco SB, Segura EL, Cura EN, Chuit R, Tulián L, Flores I, Garbarino G, Villalonga JF, Gürtler RE 2000. Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in North-Western Argentina. Trop Med Int Health 5: 293-301.
18. Blanco SB, Segura EL, Gürtler RE 1999. El control de la transmisión congénita de T. cruzi en la Argentina. Medicina (B Aires) 59 (Suppl. 2): 138-142.
19. Bocchi EA, Fiorelli A 2001. First Guideline Group for Heart Transplantation of the Brazilian Society of Cardiology. The Brazilian experience with heart transplantation: a multicenter report. J Heart Lung Transplant 20: 637-645.
20. Bosseno MF, Yacsik N, Vargas F, Brenière SF 2000. Selection of Trypanosoma cruzi clonal genotypes (clones 20 and 39) isolated from Bolivian triatomines following subculture in liquid medium. Mem Inst Oswaldo Cruz 95: 601-607.
21. Brandariz S, Schijman A, Vigliano C, Arteman P, Viotti R, Beldjord C, Levin MJ 1995. Detection of parasite DNA in Chagas' heart disease [Letter]. Lancet 346: 1370-1371.
22. Brener Z 1962. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop São Paulo 4: 389-396.
23. Brener Z, Andrade Z, M Barral-Netto 2000. Trypanosoma cruzi e doença de Chagas, 2a ed., Guanabara Koogan, Rio de Janeiro, 431 pp.
24. Brenière SF, Bosseno MF, Telleria J, Bastrenta B, Yacsik N, Noireau F, Alcazar JL, Barnabé C, Wincker P, Tibayrenc M 1998. Different behavior of two Trypanosoma cruzi major clones: transmission and circulation in young Bolivian patients. Exp Parasitol 89: 285-295.
25. Britto C, Cardoso MA, Vanni CMM, Haslocher-Moreno A, Xavier SS, Wincker P 1995. Polymerase chain reaction detection of Trypanosoma cruzi in human blood samples as a tool for diagnosis and treatment evaluation. Parasitology 110: 241-247.
26. Britto C, Cardoso MA, Wincker P, Morel CM 1993. A simple protocol for the physical cleavage of Trypanosoma cruzi kinetoplast DNA present in blood samples and its use in polymerase chain reaction (PCR)-based diagnosis of chronic Chagas disease. Mem Inst Oswaldo Cruz 88: 171-172.
27. Britto C, Silveira C, Cardoso MA, Marques P, Luquetti A, Macedo V, Fernandes O 2001. Parasite persistence in treated chagasic patients revealed by xenodiagnosis and polymerase chain reaction. Mem Inst Oswaldo Cruz 96: 823-826.
28. Burgos JM, Altcheh J, Bisio M, Duffy T, Valadares HM, Seidenstein ME, Piccinali R, Freitas JM, Levin MJ, Macchi L, Macedo AM, Freilij H, Schijman AG 2007. Direct molecular profiling of minicircle signatures and lineages of Trypanosoma cruzi bloodstream populations causing congenital Chagas disease. Int J Parasitol 37: 1319-1327.
29. Cançado JR 1963. Aspectos clínicos na padronização dos métodos de avaliação terapêutica na doença de Chagas. Rev Goiana Med 9 (Suppl.): 212-232.
30. Cançado JR 1985. Tratamento específico. In JR Cançado, M Chuster, Cardiopatia chagásica, Imprensa Oficial de Minas Gerais, Minas Gerais, p. 327-355.
31. Cançado JR 1997. Terapêutica específica. In JCP Dias, JR Coura, Clínica e terapêutica da doença de Chagas. Uma abordagem prática para o clínico geral, Fiocruz, Rio de Janeiro, p. 323-351.
32. Cançado JR 1999. Criteria of Chagas disease cure. Mem Inst Oswaldo Cruz 94 (Suppl. I): 331-335.
33. Cançado JR 2002. Long term evaluation of etiological treatment of Chagas disease with benznidazole. Rev Inst Med Trop Sao Paulo 44: 29-37.
34. Castro AM, Luquetti AO, Rassi A, Rassi GG, Chiari E, Galvão LMC 2002. Blood culture and polymerase chain reaction for the diagnosis of the chronic phase of human infection with Trypanosoma cruzi. Parasitol Res 88: 894-900.
35. Chiari E, Dias JCP, Lana M, Chiari CA 1989. Hemocultures for the parasitological diagnosis of human chronic Chagas disease. Rev Soc Bras Med Trop 22: 19-23.
36. Coronado X, Zulantay I, Rozas M, Apt W, Sánchez G, Rodríguez J, Ortiz S, Solari A 2006. Dissimilar distribution of Trypanosoma cruzi clones in humans after chemotherapy with allopurinol and itraconazole. J Antimicrob Chemother 58: 216-219.
37. Coura JR 2007. Chagas disease: what is known and what is needed - A background article. Mem Inst Oswaldo Cruz 102 (Suppl. I): 113-122.
38. Coura JR, de Castro SL 2002. A critical review on Chagas disease chemotherapy. Mem Inst Oswaldo Cruz 97: 3-24.
39. Coura JR, Junqueira AC, Fernandes O, Valente SA, Miles MA 2002. Emerging Chagas disease in Amazonian Brazil. Trends Parasitol 18: 171-176.
40. Cummings KL, Tarleton RL 2003. Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR. Mol Biochem Parasitol 129: 53-59.
41. Cunha-Neto E, Bilate AM, Hyland KV, Fonseca SG, Kalil J, Engman DM 2006. Induction of cardiac autoimmunity in Chagas heart disease: a case for molecular mimicry. Autoimmunity 39: 41-54.
42. Cunha-Neto E, Coelho V, Guilherme L, Fiorelli A, Stolf N, Kalil J 1996. Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J Clin Invest 98: 1709-1712
43. da Pinto A.S., de Lana M, Bastrenta B, Barnabé C, Quesney V, Noel S, Tibayrenc M 1998. Compared vectorial transmissibility of pure and mixed clonal genotypes of Trypanosoma cruzi in Triatoma infestans. Parasitol Res 84: 348-353.
44. da Silveira Pinto A, de Lana M, Britto C, Bastrenta B, Tibayrenc M 2000. Experimental Trypanosoma cruzi biclonal infection in Triatoma infestans: detection of distinct clonal genotypes using kinetoplast DNA probes. Int J Parasitol 30: 843-848.
45. Deane MP, Mangia RH, Pereira NM, Momen H, Gonçalves AM, Morel CM 1984. Trypanosoma cruzi: strain selection by different schedules of mouse passages of an initially mixed infection. Mem Inst Oswaldo Cruz 79: 495-497.
46. de Castro AM, Luquetti AO, Rassi A, Chiari E, Galvao LM 2006. Detection of parasitemia profiles by blood culture after treatment of chronic Trypanosoma cruzi infection. Parasitol Res 99: 379-383.
47. Duffy T, Bisio M, Altcheh J, Burgos JM, Diez M, Levin MJ, Favaloro RR, Freilij H, Schijman AG 2009. Accurate real-time PCR strategy for monitoring bloodstream parasitic loads in Chagas disease patients. PLoS Negl Trop Dis 3: e419.
48. Fabbro De Suasnábar D, Arias E, Streiger M, Piacenza M, Ingaramo M, Del Barco M, Amicone N 2000. Evolutive behavior towards cardiomyopathy of treated (nifurtimox or benznidazole) and untreated chronic chagasic patients. Rev Inst Med Trop Sao Paulo 42: 99-109.
49. Fernandes O, Santos SS, Cupolillo E, Mendonça B, Derre R, Junqueira AC, Santos LC, Sturm NR, Naiff RD, Barret TV, Campbell DA, Coura JR 2001. A mini-exon multiplex polymerase chain reaction to distinguish the major groups of Trypanosoma cruzi and T. rangeli in the Brazilian Amazon. Trans R Soc Trop Med Hyg 95: 97-99.
50. Filardi LS, Brener Z 1987. Susceptibility and natural-resistance of Trypanosoma cruzi strains to drugs used clinically in Chagas disease. Trans R Soc Trop Med Hyg 5: 755-759.
51. Fragata Filho AA, Luquetti AO, Prata A, Rassi A, Gontijo ED, Ferreira HO, Cançado JR, Andrade SG, Macedo V, Amato Neto A, Oliveira Jr W, Brener Z 1997. Ethiological treatment for Chagas' disease. Parasitol Today 13: 127-128.
52. Freilij H, Altcheh J 1995. Congenital Chagas' disease. Diagnostic and clinical aspects. Clin Infect Dis 21: 551-555.
53. Freilij H, Muller L, Gonzalez-Cappa EM 1983. Direct micromethod for diagnosis of acute and congenital Chagas disease. J Clin Microbiol 18: 327-330.
54. Freitas JM, Lages-Silva E, Crema E, Pena SD, Macedo AM 2005. Real time PCR strategy for the identification of major lineages of Trypanosoma cruzi directly in chronically infected human tissues. Int J Parasitol 35: 411-417.
55. Galleano RH, Marr JJ, Sosa RR 1990. Therapeutic efficacy of allopurinol in patients with chronic Chagas disease. Am J Trop Med Hyg 43: 159-166.
56. Galvão LMC, Chiari E, Macedo AM, Luquetti AO, Silva SA, Andrade AL 2003. PCR assay for monitoring Trypanosoma cruzi parasitemia in childhood after specific chemotherapy. J Clin Microbiol 41: 5066-5070.
57. Galvão LMC, Nines RMB, Cançado JR, Brener Z, Krettli AU 1993. Lytic antibody titre as a means of assessing cure after treatment of Chagas disease: a 10 years follow-up study. Trans R Soc Trop Med Hyg 87: 220-223.
58. Girones N, Cuervo H, Fresno M 2005. Trypanosoma cruzi-induced molecular mimicry and Chagas disease. Curr Trop Microbiol Immunol 296: 89-123.
59. Gomes ML, Galvão LM, Macedo AM, Pena SD, Chiari E 1999. Chagas disease diagnosis: comparative analysis of parasitologic, molecular and serologic methods. Am J Trop Med Hyg 60: 205-210.
60. Gomes ML, Macedo AM, Vago AR, Pena SD, Galvão LM, Chiari E 1998. Trypanosoma cruzi: optimization of polymerase chain reaction for detection in human blood. Exp Parasitol 88: 28-33.
61. Guedes PMM, Fietto JLR, Lana M, Bahia MT 2006. Advances in Chagas disease chemotherapy. Anti-Infect Agents Med Chem 5: 175-186.
62. Guzmán-Brancho C 2001. Epidemiology of Chagas disease in Mexico: an update. Trends Parasitol 17: 372-377.
63. Higuchi ML, Brito T, Reis M, Bellotti G, Pereira-Barreto AC, Pileggi F 1993. Correlation between Trypanosoma cruzi parasitism and myocardial inflammation in human chronic chagasic myocardits. Light microscopy and immunohistochemical findings. Cardiovasc Pathol 2: 101-106.
64. Iwai LK, Juliano MA, Juliano L, Kalil J, Cunha-Neto E 2005. T-cell molecular mimicry in Chagas disease: identification and partial structural analysis of multiple cross-reactive epitopes between Trypanosoma cruzi B13 and cardiac myosin heavy chain. J Autoimmun 24: 111-117.
65. Jones EM, Colley DG, Tostes S, Lopes ER, Venencak-Jones C, Mc Curley TL 1993. Amplification of Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg 48: 348-357.
66. Junqueira ACV, Chiari E, Wincker P 1996. Comparison of the polymerase chain reaction with two classical parasitological methods for the diagnosis of Chagas disease in endemic region of North-Eastern Brazil. Trans R Soc Trop Med Hyg 90: 129-132.
67. Kalil J, Cunha-Neto E 1996. Autoimmunity in Chagas disease cardiomyopathy: fulfilling the criteria at last? Parasitol Today 12: 396-399.
68. Kierszenbaum F 1999. Chagas' disease and the autoimmunity hypothesis. Clin Microbiol Rev 12: 210-223.
69. Krettli AU, Brener Z 1982. Resistance against Trypanosoma cruzi associate to anti-living trypomastigote antibodies. J Immunol 128: 2009-2012.
70. Krettli AU, Cançado JR, Brener Z 1982. Effect of specific chemotherapy on the levels of lytic antibodies in Chagas' disease. Trans R Soc Trop Med Hyg 76: 334-340.
71. Krettli AU, Cançado R, Brener Z 1984. Criterion of cure of human Chagas disease after specific chemotherapy: recent advances. Mem Inst Oswaldo Cruz 79: 157-164.
72. Lages-Silva E, Ramirez LE, Silva-Vergara ML, Chiari E 2002. Chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome: diagnosis, follow-up and genetic characterization of Trypanosoma cruzi. Clin Infect Dis 34: 118-123.
73. Lane JE, Olivares-Villagomez D, Vnencak-Jones CL, McCurley TL, Carter CE 1997. Detection of Trypanosoma cruzi with the polymerase chain reaction and in situ hybridization in infected murine cardiac tissue. Am J Trop Med Hyg 56: 588-595.
74. Lauria-Pires L, Braga MS, Vexenat AC, Nitz N, Simões-Barbosa A, Tinoco DL, Teixeira AR 2000. Progressive chronic Chagas heart disease ten years after treatment with anti-Trypanosoma cruzi nitroderivatives. Am J Trop Med Hyg 63: 111-118.
75. Lauria-Pires L, Castro CN, Emanuel A, Prata A 1988. Ineficácia do allopurinol em pacientes na fase aguda da doença de Chagas. Rev Soc Bras Med Trop 21: 79.
76. Levin MJ 1996. In chronic Chagas heart disease, don't forget the parasite. Parasitol Today 12: 415-416.
77. Luquetti A 1997. The National Health Foundation of Brazil, etiological treatment for Chagas disease. Parasitol Today 13: 127-128.
78. Machado CR, Camargos ER, Guerra LB, Moreira MC 2000. Cardiac autonomic denervation in congestive heart failure: comparison of Chagas' heart disease with other dilated cardiomyopathy. Hum Pathol 31: 3-10.
79. Maldonado C, Albano S, Vettorazzi L, Salomone O, Zlocowski JC, Abiega C, Amuchastegui M, Cordoba R, Alvarellos T 2004. Using polymerase chain reaction in early diagnosis of reactivated Trypanosoma cruzi infection after heart transplantation. J Heart Lung Transplant 23: 1345-1348.
80. Manzullo EC, Chuit R 1999. Risk of death due to chronic chagasic cardiopathy. Mem Inst Oswaldo Cruz 94 (Suppl. I): 317-320.
81. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simões MV 2007. Pathogenesis of chronic Chagas heart disease. Circulation 115: 1109-1123.
82. Marin-Neto JA, Rassi A Jr, Morillo CA, Avezum A, Connolly SJ, Sosa-Estani S, Rosas F, Yusuf S, BENEFIT Investigators 2008. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the BENznidazole Evaluation for Interrupting Trypanosomiasis (BENEFIT). Am Heart J 156: 37-43.
83. Martins HR, Moreira Silva R, Valadares HM, Toledo MJ, Veloso VM, Vitelli-Avelar DM, Carneiro CM, Machado-Coelho GL, Bahia MT, Martins-Filho OA, Macedo AM, Lana M 2007. Impact of dual infections on chemotherapeutic efficacy in BALB/c mice infected with major genotypes of Trypanosoma cruzi. Antimicrob Agents Chemother 51: 3282-3289.
84. Martins HR, Toledo MJ, Veloso VM, Carneiro CM, Machado-Coelho GL, Tafuri WL, Bahia MT, Valadares HM, Macedo AM, Lana M 2006. Trypanosoma cruzi: impact of dual-clone infections on parasite biological properties in BALB/c mice. Exp Parasitol 112: 237-246.
85. Medrano NM, Luz MRMP, Cabello P, Tapia GT, Van Leuven F, Araújo-Jorge TC 1996. Acute Chagas disease: plasma levels of alpha-2-macroglobulin and C-reactive protein in children under 13 years in a high endemic area of Bolivia. J Trop Pediatr 42: 68-74.
86. Mora MC, Sánchez Negrette O, Marco D, Barrio A, Ciaccio M, Segura MA, Basombrio MA 2005. Early diagnosis of congenital Trypanosoma cruzi infection using PCR, hemoculture and capillary concentration as compared with delayed serology. J Parasitol 91: 1468-1473.
87. Moser DR, Kirchoff LV, Donelson JE 1989. Detection of Trypanosoma cruzi by DNA amplification using the polymerase chain reaction. J Clin Microbiol 27: 1477-1482.
88. Moya PR, Moretti E, Paolasso R, Blanco S, Sanmartino C, Soich de Cura A 1989. Enfermedad de Chagas neonatal. Diagnóstico de laboratorio en el primer año de vida. Medicina (B Aires) 49: 595-599.
89. MS - Ministério da Saúde 2005. Consenso Brasileiro em Doença de Chagas. Rev Soc Bras Med Trop 38 (Suppl. III): 1-29.
90. Murta SM, Nogueira FB, Dos Santos PF, Campos FM, Volpe C, Liarte DB, Nirdé P, Probst CM, Krieger MA, Goldenberg S, Romanha AJ 2008. Differential gene expression in Trypanosoma cruzi populations susceptible and resistant to benznidazole. Acta Trop 107: 59-65.
91. Olivares-Villagómez D, McCurley TL, Vnencak-Jones CL, Correa-Oliveira R, Colley DG, Carter CE 1998. Polymerase chain reaction amplification of three different Trypanosoma cruzi DNA sequences from human chagasic cardiac tissue. Am J Trop Med Hyg 59: 563-570.
92. OPAS/OMS 1998. Tratamiento Etiológico de la Enfermedad de Chagas. Conclusiones de una consulta técnica. Rev Patol Trop 28: 247-279, 1999.
93. Piatak M Jr, Luk KC, Williams B, Lifson JD 1993. Quantitative competitive polymerase chain reaction for accurate quantitation of HIV DNA and RNA species. Biotechniques 14: 70-81.
94. Piron M, Fisa R, Casamitjana N, López-Chejade P, Puig L, Vergés M, Gascón J, Gómez i Prat J, Portús M, Sauleda S 2007. Development of a real-time PCR assay for Trypanosoma cruzi detection in blood samples. Acta Trop 103: 195-200.
95. Pontes-de-Carvalho L, Santana CC, Soares MB, Oliveira GG, Cunha-Neto E, Ribeiro-dos-Santos R 2002. Experimental chronic Chagas' disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens. J Autoimmun 18: 131-138.
96. Rassi A, Luquetti AO 1992. Therapy of Chagas disease. In S Wendel, Z Brener, E Camargo, A Rassi, Chagas disease (American trypanosomiasis): its impact on transfusion and clinical medicine, ISBT, São Paulo, p. 237-247.
97. Rassi A, Luquetti AO 2003. Specific treatment for Trypanosoma cruzi infection (Chagas disease). In KM Tyler, Miles MA, American trypanosomiasis, Kluwer Academic Publishers, Boston, p. 117-125.
98. Rassi Jr A, Rassi A, Little WC 2000. Chagas' heart disease. Clin Cardiol 23: 883-889.
99. Rassi Jr A, Rassi SG, Rassi A 2001. Sudden death in Chagas' disease. Arq Bras Cardiol 76: 75-96.
100. Revollo S, Oury B, Laurent JP, Barnabé C, Quesney V, Carriere V, Noel S, Tibayrenc M 1998. Trypanosoma cruzi: impact of clonal evolution of the parasite on its biological and medical properties. Exp Parasitol 89: 30-39.
101. Russomando G, de Tomassone MM, de Guillen I, Acosta N, Vera N, Almiron M, Candia N, Calcena MF, Figueredo A 1998. Treatment of congenital Chagas' disease diagnosed and followed up by the polymerase chain reaction. Am J Trop Med Hyg 59: 487-491.
102. Sánchez G, Coronado X, Zulantay I, Apt W, Gajardo M, Solari S, Venegas J 2005. Monitoring the efficacy of specific treatment in chronic Chagas disease by polymerase chain reaction and flow cytometry analysis. Parasite 12: 353-357.
103. Schijman AG, Altcheh J, Burgos JM, Biancardi M, Bisio M, Levin MJ, Freilij H 2003. Aetiological treatment of congenital Chagas' disease diagnosed and monitored by the polymerase chain reaction. J Antimicrob Chemother 52: 441-449.
104. Schijman AG, Vigliano C, Burgos J, Favaloro R, Perrone S, Laguens R, Levin MJ 2000. Early diagnosis of recurrence of Trypanosoma cruzi infection by polymerase chain reaction after heart transplantation of a chronic Chagas' heart disease patient. J Heart Lung Transplant 19: 1114-1117.
105. Schofield CJ, Dias JCP 1999. The Southern Cone Initiative against Chagas disease. Adv Parasitol 42: 1-27.
106. Silva JS, Rossi MA 1990. Intensification of acute Trypanosoma cruzi myocarditis in BALB/c mice pretreated with low doses of cyclophosphamide or gamma irradiation. J Exp Pathol 71: 33-39.
107. Solari A, Ortíz S, Soto A, Arancibia C, Campillay R, Contreras M, Salinas P, Rojas A, Schenone H 2001. Treatment of Trypanosoma cruzi-infected children with nifurtimox: a 3 year follow-up by PCR. J Antimicrob Chemother 48: 515-519.
108. Sosa-Estani S, Segura EL 1999. Treatment of Trypanosoma cruzi infection in the undetermined phase. Experience and current guidelines of treatment in Argentina. Mem Inst Oswaldo Cruz 94 (Suppl. I): 363-365.
109. Sosa-Estani S, Segura EL 2006. Etiological treatment in patients infected by Trypanosoma cruzi: experiences in Argentina. Curr Opin Infect Dis 19: 583-587.
110. Sosa-Estani S, Segura EL, Ruiz AM, Velazquez E, Porcel BM, Yampotis C 1998. Efficacy of chemotherapy with benznidazole in children in the indeterminate phase of Chagas disease. Am J Trop Med Hyg 59: 526-529.
111. Sturm NR, Degrave W, Morel CM, Simpson L 1989. Sensitive detection by amplification of kinetoplast minicircle DNA sequences: use in diagnosis of Chagas disease. Mol Biochem Parasitol 33: 205-214.
112. Tarleton RL 2001. Parasite persistence in the aetiology of Chagas disease. Int J Parasitol 31: 550-554.
113. Tarleton RL, Reithinger R, Urbina JA, Kitron U, Gürtler RE 2007. The challenges of Chagas disease - grim outlook or glimmer of hope? PLoS Med 4: 1852-1857.
114. Tarleton RL, Zhang L 1999. Chagas' disease etiology: autoimmunity or parasite persistence? Parasitol Today 15: 94-99.
115. Tibayrenc M, Ward P, Moya A, Ayala FJ 1986. Natural populations of Trypanosoma cruzi, the agent of Chagas disease, have a complex multiclonal structure. Proc Natl Acad Sci USA 83: 115-119.
116. Toledo MJ, Bahia MT, Carneiro CM, Martins-Filho OA, Tibayrenc M, Barnabé C, Tafuri WL, de Lana M 2003. Chemotherapy with benznidazole and itraconazole for mice infected with different Trypanosoma cruzi clonal genotypes. Antimicrob Agents Chemother 47: 223-230.
117. Toledo MJ, Bahia MT, Veloso VM, Carneiro CM, Machado-Coelho GL, Alves CF, Martins HR, Cruz RE, Tafuri WL, Lana M 2004. Effects of specific treatment on parasitological and histopathological parameters in mice infected with different Trypanosoma cruzi clonal genotypes. J Antimicrob Chemother 53: 1045-1053.
118. Urbina JA 2001. Specific treatment of Chagas disease: current status and new developments. Curr Opin in Infect Dis 14: 733-741.
119. Urbina JA, Docampo R 2003. Specific chemotherapy of Chagas disease: controversies and advances. Trends Parasitol 19: 495-501.
120. Vago AR, Macedo AM, Adad SJ, Reis DD, Corrêa-Oliveira R 1996. PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas' disease. Lancet 348: 891-892.
121. Villa L, Morote S, Bernal O, Bulla D, Albajar-Vinas P 2007. Access to diagnosis and treatment of Chagas disease/infection in endemic and non-endemic countries in the XXI century. Mem Inst Oswaldo Cruz 102 (Suppl. I): 87-93.
122. Viotti R, Vigliano C, Armenti H, Segura E 1994. Treatment of chronic Chagas disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am Heart J 127: 151-162.
123. Viotti R, Vigliano C, Lococo B, Bertocchi G, Petti M, Alvarez MG, Postan M, Armenti A 2006. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med 144: 724-734.
124. Virreira M, Martínez S, Alonso-Vega C, Torrico F, Solano M, Torrico MC, Parrado R, Truyens C, Carlier Y, Svoboda M 2006. Amniotic fluid is not useful for diagnosis of congenital Trypanosoma cruzi infection. Am J Trop Med Hyg 75: 1082-1084.
125. Virreira M, Torrico F, Truyens C, Alonso-Vega C, Solano M, Carlier Y, Svoboda M 2003. Comparison of polymerase chain reaction methods for reliable and easy detection of congenital Trypanosoma cruzi infection. Am J Trop Med Hyg 68: 574-582.
126. Virreira M, Torrico F, Truyens C, Alonso-Vega C, Solano M, Carlier Y, Svoboda M 2005. Comparison of PCR methods for the diagnosis of congenital Trypanosoma cruzi infection. Rev Soc Bras Med Trop 38 (Suppl. II): 65-67.
127. Wendel S, Dias JCP 1992. Transfusion transmitted Chagas disease. In S Wendel, Z Brener, E Camargo, A Rassi, Chagas disease (American trypanosomiasis): its impact on transfusion and clinical medicine, ISBT, São Paulo, p. 103-134.
128. WHO - World Health Organization 1991. Control of Chagas disease. WHO Techn Rep Sers 811: 2-11.
129. WHO - World Health Organization 2005. Chagas disease. Seventeenth Programme Report UNDP/TDR, Geneva.
130. Winker P, Bosseno MF, Britto C, Yaksic N, Cardoso MA, Morel CM, Brenière SF 1994a. High correlation between Chagas' disease serology and PCR-based detection of Trypanosoma cruzi kinetoplast DNA in Bolivian children living in an endemic area. FEMS Microbiol Lett 124: 419-423.
131. Winker P, Britto C, Borges Pereira J, Cardoso MA, Oelemann W, Morel CM 1994b. Use of simplified polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients in a rural endemic area. Am J Trop Med Hyg 51: 771-777.
132. Winker P, Telleria J, Bosseno MF, Cardoso MA, Marques P, Yaksic N, Aznar C, Liegeard P, Hontebeyrie M, Noireau F, Morel CM, Brenière SF 1997. PCR-based diagnosis for Chagas' disease in Bolivian children living in an active transmission area: comparison with conventional serology and parasitological diagnosis. Parasitology 114: 367-373.
133. Zingales B, Souto RP, Mangia RH, Lisboa CV, Campbell DA, Coura JR, Jansen A, Fernandes O 1998. Molecular epidemiology of American trypanosomiasis in Brazil based on dimorphisms of rRNA and mini-exon gene sequences. Int J Parasitol 28: 105-112.
134. Zulantay I, Honores P, Solari A, Apt W, Ortiz S, Osuna A, Rojas A, López B, Sánchez G 2004. Use of polymerase chain reaction (PCR) and hybridization assays to detect Trypanosoma cruzi in chronic chagasic patients treated with itraconazole or allopurinol. Diag Microbiol Infect Dis 48: 253-257.